---

Highlights of November 2020

1. Goldman Sachs invests US$150 Million in Biocon arm.
2. Laurus Labs enters biotechnology segment by acquiring a 73% stake majority stake in Richcore Lifesciences Hyderabad for ~$35 Million.
3. Biocon to acquire 26% stake in Hinduja Renewables Two.
4. Jubilant Life Sciences arm enters into strategic partnership with SOFIE Biosciences.
5. Cipla has signed a licensing agreement with Multi G in Belgium for the distribution of its Covid-19 rapid antibody test kit, Covi-G, in Europe and other emerging markets.
6. Dr Reddy's Labs to Acquire Select Anti-Allergy Brands of Glenmark
7. Hetero Drugs Signs Deal to Produce 100 million Doses of Russian Sputnik-V COVID-19 Vaccine in India.
8. Boston Scientific recoups US$800 Million by selling off BTG's antidote business.
9. Merck inks US$425M OncoImmune buyout to bag COVID-19 drug.
10. Lilly, Precision Biosciences team up on Duchenne gene therapy in US$135 Million deal.
11. GE Healthcare acquires Swedish developer of CT image-boosting photon detectors.

Highlights at Aagami:

• Aagami to attend JPM week and Biotech Showcase (happening digitally) in January 2021. Partnering portal open and we are currently accepting
• Aagami celebrates its 18th Anniversary by offering special pricing to its clients (Offer period Dec 2020 – Feb 2021, please contact us for more details)

• IMPORTANT: Our Office address is reverted to 2020 Calamos Court, Suite 200, Naperville IL 60563 USA. It is just across the road from the earlier address. Kindly make a note of it.